共 50 条
[46]
A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg
[J].
Bone Marrow Transplantation,
2019, 54
:258-264
[47]
A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg
[J].
BONE MARROW TRANSPLANTATION,
2019, 54 (02)
:258-264
[50]
Postoperative outcomes among Northern versus Southern Ontario patients undergoing common intermediate- to high-risk elective surgeries: a population-based cohort study; [Comparaison des issues postopératoires de la patientèle bénéficiant de chirurgies non urgentes courantes à risque intermédiaire à élevé entre le Nord et le Sud de l’Ontario : une étude de cohorte basée sur la population]
[J].
Canadian Journal of Anesthesia/Journal canadien d'anesthésie,
2024, 71 (12)
:1705-1715